NEUREXAN cpr 50 pce

7680622420016 CH-62242 20.01.1.
NEUREXAN cpr 50 pce
NEUREXAN cpr 50 pce
1 / 2
google

Details

Product number
6224201
CPT
-
Packaging group
50
Unit
Tablette(n)
Composition
avena sativa (HAB) D2 0.6 mg, coffea arabica (HAB) D12 0.6 mg, passiflora incarnata (HAB) D2 0.6 mg, zincum isovalerianicum (HAB) D4 (HAB 5a) 0.6 mg, lactosum monohydricum 300.0 mg, magnesii stearas, pro compresso 301.5 mg.

Articles (1)

Neurexan, Tabletten
Tabletten
50
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
12/11/2024
Patient information leaflet
Français
12/11/2024
Patient information leaflet
Italien
12/11/2024

Detailed composition

Substance Quantity Type Category
(N/A)
0.6 MG Substance Wirkstoff (Principe actif)
(N/A)
0.6 MG Substance Wirkstoff (Principe actif)
(N/A)
0.6 MG Substance Wirkstoff (Principe actif)
(N/A)
0.6 MG Substance Wirkstoff (Principe actif)
(N/A)
300.0 MG Substance HBESI
(N/A)
- Substance HNIDK

Authorization holder

ebi-pharm ag

3038 Kirchlindach

Authorization information

Swissmedic authorization number
62242
Drug name
Neurexan, Tabletten
Galenic form
TAB
Authorization status
Z
Dispensation category
D
First authorization
18/06/2012
Authorization expiration date
31/12/9999
IT number
20.01.1.
Domain
Human medicine
Field of application
Gemäss homöopathischem Arzneimittelbild bei Schlafstörungen und nervösen Unruhezuständen

Packaging details

Description (FR)
NEUREXAN cpr 50 pce
Description (DE)
NEUREXAN Tabl 50 Stk
Market launch
18/06/2012
Narcotic (BTM)
No

Other packaging sizes